Index by author

February 15, 2022; Volume 19,Issue 2

  1. An, Na

    1. Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

  2. Bi, Jinghao

    1. Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
      Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
      Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634

  3. Cao, Lei

    1. Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

  4. Chen, Yiyu

    1. The advance of adjuvant treatment for triple-negative breast cancer
      Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
      Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752

  5. Davidson, Nancy E.

    1. Updates in endocrine therapy for metastatic breast cancer
      Poorni M. Manohar and Nancy E. Davidson
      Cancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255

  6. Ding, Kefeng

    1. Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532

  7. Ding, Yuwei

    1. Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
      Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
      Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213

  8. Dong, Jilin

    1. Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
      Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
      Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560

  9. Du, Guanhua

    1. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
      Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
      Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651

  10. Fu, Dongliang

    1. Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
      Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
      Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
« Previous (Pages : 1 2 3 4 5 6 ... 9) Next »
Back to top

In this issue

Cancer Biology & Medicine: 19 (2)
Cancer Biology & Medicine
Vol. 19, Issue 2
15 Feb 2022

Submit

Sign up for alerts